AstraZeneca PLC Reports AGM Results
Ticker: AZN · Form: 6-K · Filed: Apr 9, 2026 · CIK: 0000901832
| Field | Detail |
|---|---|
| Company | Astrazeneca PLC (AZN) |
| Form Type | 6-K |
| Filed Date | Apr 9, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: AGM, corporate-governance, filing-update
TL;DR
AstraZeneca's AGM results are in, shareholders voted on key resolutions.
AI Summary
AstraZeneca PLC filed a Form 6-K on April 9, 2026, reporting the results of its Annual General Meeting (AGM). The filing details the outcomes of resolutions voted on by shareholders during the meeting.
Why It Matters
This filing provides shareholders with the official results of voting on key company matters at the Annual General Meeting, reflecting shareholder sentiment on corporate governance and strategic decisions.
Risk Assessment
Risk Level: low — This is a routine filing reporting the results of an Annual General Meeting, which is standard corporate practice and does not indicate new risks.
Key Players & Entities
- ASTRAZENECA PLC (company) — Filer
- 0000901832 (company) — CIK
- 0001654954-26-003374 (filing_id) — SEC Accession Number
- 2026-04-09 (date) — Filing Date and Period of Report
FAQ
What type of report is this SEC filing?
This is a Form 6-K, which is a Report of foreign issuer.
When was this filing accepted by the SEC?
The filing was accepted on April 9, 2026.
What is the CIK number for AstraZeneca PLC?
The CIK number for AstraZeneca PLC is 0000901832.
What is the primary document included in this filing?
The primary document is a report on the 'RESULT OF AGM' (Annual General Meeting).
Where is AstraZeneca PLC's mailing address listed?
AstraZeneca PLC's mailing address is listed as 1 FRANCIS CRICK AVENUE, CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE, United Kingdom, CB2 0AA.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 9, 2026 regarding ASTRAZENECA PLC (AZN).